Shorter radiation after robotic surgery for HPV throat cancer
Part of Cancer clinical trials.
This study tests whether a shorter course of radiation therapy after robotic throat surgery works as well as standard treatment for people with HPV-related throat cancer. It's for patients who have had robotic surgery and whose cancer is HPV-positive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have HPV-related throat cancer (oropharyngeal squamous cell carcinoma)
- You are able to have transoral robotic surgery (TORS) to remove the tumor
- You have not smoked cigarettes in the last month
- You are willing to have blood tests for TTMV-HPV DNA before and after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether we can safely use lower doses of radiation for people with HPV-related throat cancer, while still targeting the areas that need it. The goal is to reduce side effects without lowering the chance of a cure.
This study tests a way to use less radiation for HPV-related throat cancer. Doctors will adjust your treatment based on a simple blood test that tracks cancer DNA, so you may get only the treatment you need.
This trial tests whether using a lower intensity (reduced) chemo-radiation plan can work for some people with HPV-related oropharyngeal (throat) cancer without losing effectiveness. It may help reduce side effects while still controlling the cancer.
This Phase 2 trial compares two standard cancer treatments—radiation or surgery through the mouth—for HPV-negative oropharyngeal throat cancer. It aims to find out which approach works better while keeping side effects and quality of life acceptable.
This trial tests a lower dose of radiation to certain neck areas for people with HPV-related oropharyngeal cancer. The goal is to see if reducing radiation can cause fewer side effects while still curing the cancer.
This trial tests whether giving less radiation after surgery is safe and effective for people with early-stage HPV-related throat cancer. It aims to reduce side effects while still controlling the cancer.
Hear when a new Oropharyngeal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.